To assess the factors facilitating the prediction of the frequency of ethanol injections in successful renal cyst ablation.
INTRODUCTION
Recently, percutaneous ablation has become a commonly used method in the treatment of renal cysts, and our preferred method for this procedure is multiple session sclerotherapy using ethanol. In this case, in order to decide upon a treatment plan, it is very important for both the patient and the physician to know whether the average length of stay in hospital or the number of ethanol injections needed can be predicted, but there has not yet been any research on criteria for making these predictions prior to treatment. Thus, the present study aimed to examine findings from pre-treatment imaging that could predict the number of ethanol injections.
MaTeRIals aND MeThODs

Patient Population
This retrospective study was approved by our Institutional Review Board, and the need for written informed consent was The included patients were diagnosed with renal cysts either at our hospital or another hospital using abdominal computed tomography (CT) or abdominal ultrasonography (USG). Three patients without pre-procedure CT or USG images were ultimately excluded from the study, and the remaining 36 patients (37 renal cysts) were included in the analysis. The mean time between imaging and treatment was 24 days (range: 1-130 days).
Twenty-two cysts were asymptomatic, or were discovered incidentally during examinations for other diseases, while the presence of fifteen cysts were accompanied by symptoms of flank pain, flank discomfort, abdominal pain, or hematuria.
For patients with CT images, we only included those patients with benign cysts corresponding to Bosniak classification I or II. For the two patients without CT images, prior to including them in the study, we confirmed that there was no solid portion or thick wall of 1 mm or greater in size on USG examination.
Renal cyst cytology was performed on the fluid obtained during renal cyst ablation, and malignant cells were not observed in any of the patients. The majority of patients underwent treatment due to symptoms such as abdominal or flank pain. Asymptomatic patients were treated when the cyst measured at least 5 cm in diameter, and/or when the patients themselves wanted treatment.
Imaging Analysis
Two genitourinary radiologists confirmed the radiological findings retrospectively, with a conclusion reached by consensus when there were conflicting opinions. CT findings were considered when CT images were available, while USG findings were used in the analysis of the two patients who did not have The renal cyst in the right kidney shows calcification (white arrows) and septa (black arrows) in non-contrast-enhanced (A) and contrastenhanced (B) axial computed tomography scans. In addition, it has a lobulated margin (white arrowheads) with at least one lobule. C. Like the axial axis view, the coronal axis view shows a lobulated margin (arrowheads) with at least one lobule; since the lobulated margin is visible in two planes, this cyst was classified as a lobulated renal cyst with calcification and thin septa. In all patients, a contrast agent was injected to check that there was no communication with the pelvicalyceal collecting system, extravasation, or leakage of the contrast agent into the retroperitoneum. At this point, the fluid in the cyst was aspirated as much as possible and, after noting the volume of the aspirated fluid, it was subjected to cytological and biochemical examinations. Following aspiration, sclerotherapy was performed using 99% ethanol; the amount of ethanol injected was onethird the total volume of the aspirated fluid, but no more than 100 cc. Following the injection of the ethanol into the renal cyst, to achieve an even application, the patient was placed in the supine, prone, and both decubitus positions for five minutes each, and then the ethanol was removed. The drainage volume after 24 hours was inspected via the catheter, and after using USG to check for any remaining fluid in the cyst, aspiration was performed with a 10 cc syringe. When the total drainage volume after 24 hours was over 5 cc, ethanol was injected to a volume of one-third the total drainage volume, but no more than 100 cc, and further follow-up examinations were performed after another 24 hours. When the total drainage volume was 5 cc or less, the procedure was considered a complete success and the pigtail catheter was removed (1).
Statistical Analysis
We examined the correlation between the number of ethanol injections, and the following four criteria: volume, septa (or not), calcification (or not), and margin (lobulated or smooth).
The mean total number of ethanol injections was obtained, and the subjects were divided into an "above" group and a "below" group based on the rounded mean; the volume, septa (or not), calcification (or not), and margin (lobulated or smooth) were then compared between the two groups.
An independent sample t-test was used to compare the volume between the two groups. Due to the small sizes of the two groups, 
ResUlTs
A total of 37 renal cysts were included in the study, and renal cyst ablation was performed 2.5 times on average (range: 1-7 times). And all patients were no significant problem except mi- between results for the "above-four" group and the "below-three" group. The subjects were divided according to the number of rounds of renal cyst ablation, with the "above-four" group including those who underwent at least four ethanol injections, and the "below-three" group including those who underwent three or fewer ethanol injections. nor pain at procedure site. The mean number of procedures was rounded to three, and the subjects were divided into two groups based on this criterion. There were six cases in the "above-four" group and 31 cases in the "below-three" group.
The mean volume of the renal cysts was 319.12 cc, with a mean volume of 409.48 cc in the "above-four" group and 301.64 cc in the "below-three" group. The difference between the two groups was not statistically significant (p = 0.408) ( Table 1) .
A total of seven cases showed calcification, with three such cases in the "above-four" group and four cases in the "belowthree" group. This was not a statistically significant difference (p = 0.068) ( Table 1) .
A total of 12 cases showed septa, of which only one case was in the "above-four" group and 11 cases were in the "belowthree" group. With a p-value of only 0.350, this was also not a statistically significant difference (Table 1) .
Finally, there were three cases in total with lobulated margins, of which only one case was in the "above-four" group and the other two cases were in the "below-three" group. With a p-value of 0.421, this was not a statistically significant difference (Table 1) .
DIsCUssION
Renal cysts are the most common disease in the kidneys, and are known to occur in approximately 50% of the population aged 50 years and older. Treatment is indicated in patients with symptoms such as pain, hematuria, hypertension, or pelvicalyceal dilatation due to pressure from the cyst, as well as in some patients in who the diameter of the cyst is at least 5 cm (2-6). Renal cyst sclerotherapy is a minimally invasive method for the treatment of renal cysts. It is being used increasingly often due to its high performance relative to cost and good success rate (3).
Drugs used for renal cyst sclerotherapy include ethanol, minocycline hydrochloride, povidone iodine, acetic acid, ethanolamine oleate and holmium-166 chitosan complex. Of these, ethanol is the most widely used because it is considered to be safer and more effective than the other drugs (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . The present study used 99% ethanol.
When a sclerosing agent such as ethanol is injected into a renal cyst, one of the best-known mechanisms of cyst ablation is necrosis of the fluid-secreting epithelium via coagulation (19, 20) .
In addition, the space for the cyst to grow into is believed to be multicenter study, to identify predictive factors for the number of ethanol injections administered in percutaneous renal cyst sclerotherapy. Hence, the study' s greatest limitation was the small number of cases included. Another limitation of this study is that the cyst features were examined by USG for two cases, which could have resulted in differences between these cases and the cases examined by CT.
The average number of ethanol injections for successful renal cyst sclerotherapy was 2.5 (average length of hospital stay was 6.8 days), and this number was not greatly affected by features including renal cyst volume, intracystic septa, or a lobulated margin. However, wall and septal calcification showed a relatively significant p-value of 0.068, suggesting the need for future research in a multicenter study with a larger patient population.
In conclusion, there were no significantly correlated factors for predicting the number of renal cyst ablations. However, in our study, calcification was determined to be the most useful factor for predicting the number of renal cyst ablations that may be performed. Additional research is needed to clarify this correlation.
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